Roche Diagnostics Licenses the Technology used for the LightCycler„¥ System to BIOTECON

(PresseBox) ( Mannheim, )
Roche Diagnostics and BIOTECON Diagnostics GmbH, Potsdam , Germany, have entered into a licensing agreement concerning Roche's LightCycler system technology. Under the terms of the agreement, Roche grants a non-exclusive worldwide license to BIOTECON authorizing them to develop, produce, and sell kits in the food and GMO (Genetically Modified Organisms) analysis field that are designed for use on the Roche LightCycler Instrument. The agreement includes the use of Roche's melting curve analysis technology. Financial terms of the agreement were not disclosed.

As an international biotechnology company BIOTECON Diagnostics develops, produces, and markets its innovative complete rapid PCR-based kits for the detection of pathogenic contamination in food, for spoilage microorganisms, and for genetically modified organisms. The company offers solutions for the food and beverage industry as well as for producers of pharmaceuticals and cosmetics.

With the licensing of the LightCycler instrument technology, BIOTECON will enhance the technological development and broaden the spectrum of applications especially in the fields of food and cosmetics," states Dr. Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.

"The LightCycler System Technology License represents a significant milestone for our company", states Kornelia Berghof-Jäger, CEO of BIOTECON Diagnostics. It enables us to strengthen our position in the field of molecular food diagnostics and, together with the food industry, provide even greater food safety."

About BIOTECON Diagnostics GmbH

BIOTECON Diagnostics GmbH with its headquarter in Potsdam / Berlin (Germany) has been a competent partner for molecular biological and microbiological issues for more than ten years. The focus is the development, production and marketing of PCR-based rapid detection systems. BIOTECON Diagnostics offers solutions for the food and beverages industry as well as for pharmaceutical and cosmetics manufacturers.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an